Protalix BioTherapeutics files corporate presentation; no material new information

Protalix BioTherapeutics, Inc.

Filing reports posting of May 2026 corporate presentation to company website under Item 7.01.
Exhibit 99.1 contains only title slides with general corporate description and date change from June 2024 to May 2026.
No financial results, guidance updates, or operational milestones disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.